#Latest news with #大塚ホールディングスBloomberg8 hours agoBusinessBloombergOtsuka Jumps Most in Five Years on Successful Kidney Drug TrialJapanese drugmaker Otsuka Holdings Co. surged the most in more than five years after a late-stage study of its experimental drug to treat chronic kidney disease showed benefit. The stock surged as much as 10% in Tokyo trading Monday, the largest intraday gain since March 2020.
Bloomberg8 hours agoBusinessBloombergOtsuka Jumps Most in Five Years on Successful Kidney Drug TrialJapanese drugmaker Otsuka Holdings Co. surged the most in more than five years after a late-stage study of its experimental drug to treat chronic kidney disease showed benefit. The stock surged as much as 10% in Tokyo trading Monday, the largest intraday gain since March 2020.